Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial record history.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page history.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.3%

- Check83 days agoChange DetectedA government funding/operating status notice was added and the page revision updated from v3.4.0 to v3.4.1, removing the prior v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.